How do I hire a fractional head of revenue for a medical device company in 2027?
Direct Answer
Hiring a fractional head of revenue for a medical device company in 2027 is a strategic decision driven by capital efficiency and the need for specialized go-to-market expertise without a full-time executive commitment. You are looking for someone who understands the complex regulatory sales cycles (FDA clearance, hospital procurement, reimbursement coding) and can build a scalable revenue engine from your current stage. The cost range above reflects the variability in scope: a pre-revenue startup needing 10 days/month of strategic guidance will be at the low end; a Series A company requiring 20 days/month plus hands-on pipeline management, channel partner setup, and board reporting will be at the high end. The key is to find a fractional CRO who has *sold into* the medical device ecosystem, not just adjacent industries like SaaS or medtech software.
Why Medical Device Is Different from Other B2B Revenue Leadership
Medical device companies face a unique revenue challenge: the buyer is not a single person but a network of decision-makers with conflicting priorities. The surgeon wants clinical outcomes, the hospital administrator wants cost containment, the GPO wants compliance, and the reimbursement team wants clear coding. A fractional CRO from a SaaS background will default to "land and expand" or "product-led growth" — both mostly irrelevant here. You need someone who can map a hospital system's capital equipment budget cycle (often calendar-year based) and align your sales process to it.
In 2027, the regulatory environment has not simplified. FDA 510(k) clearance, CE marking under MDR, and ISO 13485 compliance are table stakes. Your fractional head of revenue must be able to speak credibly with your clinical team about how these impact sales messaging — not to replace your regulatory expert, but to ensure the sales deck doesn't promise something the device hasn't been cleared for. This is a common failure point: founders hire a great SaaS CRO who overpromises on clinical claims, triggering compliance risk.
The Fractional CRO vs. VP of Sales Decision
Many founders confuse "fractional head of revenue" with "fractional VP of Sales." They are not the same. A fractional CRO owns the entire revenue function: sales, marketing, customer success, channel partnerships, and revenue operations. A fractional VP of Sales typically only manages the direct sales team and pipeline. For a medical device company in 2027, you almost always need a fractional CRO because the revenue engine is underdeveloped — you need someone who can build the marketing-qualified lead (MQL) definition, set up a CRM like Salesforce or HubSpot for medical device workflows, and design a channel partner program for distributors.
If your company is pre-revenue and you have no sales team, a fractional VP of Sales is premature. You need a fractional CRO who can act as both strategist and closer. If you already have 5+ sales reps and a marketing function, a fractional VP of Sales might suffice, but you'll still miss the cross-functional coordination that a CRO provides.
How to Evaluate Fractional CRO Candidates for Medical Device
Your interview process should be structured around three competencies: domain fluency, operational rigor, and cultural fit. Domain fluency is non-negotiable — ask for specific examples of hospital system sales cycles, GPO contract negotiations, and reimbursement strategy. Operational rigor means they can show you a pipeline review template they've used, a sales playbook they've written, and a CRM dashboard they've built. Cultural fit is trickier: medical device founders are often clinically trained (MDs, PhDs) and value precision over speed. A fractional CRO who talks about "growth hacking" will feel alien.
Use a 90-day plan deliverable as a litmus test. Ask each candidate to write a one-page outline of what they would do in the first 90 days. Strong candidates will include: a revenue audit (current pipeline, team skills, tech stack), a 6-month revenue forecast with assumptions, a hiring plan for key roles (SDR, channel manager), and a set of leading indicators to track weekly. Weak candidates will write vague goals like "build pipeline" or "improve conversion."
Compensation Structure: Cash, Equity, and Milestones
Fractional CRO compensation for medical device companies in 2027 typically breaks into three components. Cash retainer is the largest piece, paid monthly for a fixed number of days. The range of $8,000–$25,000/month depends on: (a) days per month (10 vs. 20), (b) company stage (pre-revenue pays less than Series A), and (c) geographic expectations (remote vs. on-site visits). Equity is usually 0–5% of fully diluted shares, vesting over 2–3 years with a 6-month cliff. Some fractional CROs will accept a higher equity percentage in lieu of cash for very early-stage companies, but this is rare — most fractional executives need cash flow.
Milestone bonuses are increasingly common. For example, $5,000–$15,000 upon achieving a specific revenue target (e.g., first $100K in new ARR, or first hospital system contract signed). These bonuses align the fractional CRO with outcomes without requiring a full-time salary commitment. Avoid tying bonuses to vanity metrics like "number of meetings booked" — focus on closed-won revenue or qualified pipeline value.
The Role of Technology in Medical Device Revenue Operations
A fractional CRO will likely recommend or implement a tech stack that includes: Salesforce or HubSpot for CRM (medical device companies often need custom fields for regulatory status, hospital system hierarchy, and GPO contract terms), Outreach or Salesloft for sales engagement (but only if you have a sales development team), and Gong for call recording and coaching (useful for training reps on complex clinical conversations). Clari for revenue forecasting is common at later stages.
Do not let the fractional CRO over-engineer the tech stack in month one. A medical device company with fewer than 10 employees does not need a revenue intelligence platform. The priority should be: (1) a clean CRM with accurate pipeline data, (2) a simple sales process documented in a playbook, and (3) a weekly revenue review cadence. The fractional CRO should be able to operate with a spreadsheet and a CRM for the first 60 days before adding tools.
FAQ
What is the typical engagement length for a fractional CRO in medical device? Most engagements run 6–12 months, often structured as a 3-month pilot with a 30-day out clause. Some founders extend to 18 months if the company is scaling quickly. The relationship usually ends when the company hits $3M–$5M ARR and can justify a full-time CRO.
Can a fractional CRO work remotely for a medical device company? Yes, but expect at least one on-site visit per quarter to meet the clinical team, attend a trade show (e.g., MD&M, FIME), or visit a hospital system. Remote fractional CROs are common in 2027, but medical device sales often require in-person demos and relationship building.
How do I know if I need a fractional CRO versus a fractional VP of Sales? If you have no sales team and need to build the entire revenue function (marketing, sales, partnerships, ops), hire a fractional CRO. If you have 3+ sales reps and a marketing person and just need pipeline management, a fractional VP of Sales may suffice.
What should I look for in a fractional CRO's background? Prior experience selling medical devices or capital equipment into hospitals, IDNs, or surgery centers. Bonus if they have worked with GPOs (Vizient, Premier, HealthTrust). Avoid candidates whose only experience is selling software to medical device companies — that is a different skill set.
How do I structure a pilot to minimize risk? Use a 3-month pilot with a 30-day out clause. Define 3–5 KPIs in the contract (e.g., pipeline value created, qualified opportunities, sales playbook delivered). Pay monthly. If the fractional CRO misses KPIs by month two, you can exit without severance.
Will a fractional CRO help me raise funding? Yes, a good fractional CRO will build a revenue model, pipeline forecast, and sales narrative that investors expect. They can also join board meetings and investor calls. This is a common reason founders hire fractional CROs pre-Series A.
What happens if the fractional CRO leaves mid-engagement? Have a backup plan: document all processes in a shared folder (playbook, CRM notes, partner contacts). Most fractional CROs provide a 30-day transition notice. CRO Syndicate and other networks can replace a fractional CRO within 2–4 weeks.
Can I hire a fractional CRO from a different industry if they are a fast learner? Rarely. Medical device revenue cycles, regulatory requirements, and buyer psychology are too specific. A fast learner will take 6–12 months to become effective — by then you could have hired a domain expert who delivers in 30 days.
How do I find fractional CRO candidates who specialize in medical device?
What is the difference between a fractional CRO and an interim CRO? A fractional CRO works part-time (10–20 days/month) and typically has multiple clients. An interim CRO works full-time for a defined period (e.g., 6 months) and replaces a departed executive. For most early-stage medical device companies, fractional is more cost-effective.